期刊
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
卷 11, 期 1, 页码 78-88出版社
SPRINGER
DOI: 10.1007/s11910-010-0158-7
关键词
Charcot-Marie-Tooth; Hereditary; Neuropathy; Genetics; Therapy; Disease pathomechanism
资金
- National Institutes of Health [R01 NS41319A, U54NS065712]
- Muscular Dystrophy Association (MDA)
- Charcot Marie Tooth Association (CMTA)
Charcot-Marie-Tooth disease (CMT) disease encompasses a genetically heterogeneous group of inherited neuropathies, also known as hereditary motor and sensory neuropathies. CMT results from mutations in more than 40 genes expressed in Schwann cells and neurons causing overlapping phenotypes. The classic CMT phenotype reflects length-dependent axonal degeneration characterized by distal sensory loss and weakness, deep tendon reflex abnormalities, and skeletal deformities. Recent articles have provided insight into the molecular pathogenesis of CMT, which, for the first time, suggest potential therapeutic targets. Although there are currently no effective medications for CMT, multiple clinical trials are ongoing or being planned. This review will focus on the underlying pathomechanisms and diagnostic approaches of CMT and discuss the emerging therapeutic strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据